Ledipasvir/sofosbuvir product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 10 July 2025 - 8:56
Ledipasvir/sofosbuvir product-specific bioequivalence guidance
Ledipasvir/sofosbuvir film-coated tablet 45 mg/200 mg and 90 mg/400 mg, coated granules 33.75mg/150mg and 45mg/200mg product-specific bioequivalence guidance - Revision 1
Submitted by Anonymous (not verified) on 10 July 2025 - 8:55
Ledipasvir/sofosbuvir film-coated tablet 45 mg/200 mg and 90 mg/400 mg, coated granules 33.75mg/150mg and 45mg/200mg product-specific bioequivalence guidance - Revision 1
EMEA-003549-PIP01-23
Submitted by Anonymous (not verified) on 9 July 2025 - 19:47
EMEA-003549-PIP01-23
EMEA-003616-PIP01-24
Submitted by Anonymous (not verified) on 9 July 2025 - 19:30
EMEA-003616-PIP01-24
EMEA-003521-PIP01-23
Submitted by Anonymous (not verified) on 9 July 2025 - 19:11
EMEA-003521-PIP01-23
EMEA-003513-PIP01-23
Submitted by Anonymous (not verified) on 9 July 2025 - 18:14
EMEA-003513-PIP01-23
EMEA-003610-PIP01-24
Submitted by Anonymous (not verified) on 9 July 2025 - 17:31
EMEA-003610-PIP01-24
EMEA-003628-PIP01-24
Submitted by Anonymous (not verified) on 9 July 2025 - 17:25
EMEA-003628-PIP01-24
EMEA-003502-PIP01-23
Submitted by Anonymous (not verified) on 9 July 2025 - 17:14
EMEA-003502-PIP01-23
EMEA-003622-PIP01-24
Submitted by Anonymous (not verified) on 9 July 2025 - 17:07
EMEA-003622-PIP01-24